Pretreatment with memantine prevents Alzheimer-like alterations induced by intrahippocampal okadaic acid administration in rats.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Alzheimer Research

• Publication date

  2012-11-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/156720512804142877PMID 22515493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice

  2012cited by this paper
• Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

  2011cited by this paper
• The role of Cdk5 in cognition and neuropsychiatric and neurological pathology.

  2011cited by this paper
• Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.

  2011cited by this paper
• Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease.

  2011cited by this paper
• Memantine prevents aluminum-induced cognitive deficit in rats.

  2011cited by this paper
• Molecular mechanisms of neurodegeneration in Alzheimer's disease.

  2010cited by this paper
• Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

  2010cited by this paper
• An okadaic acid-induced model of tauopathy and cognitive deficiency.

  2010cited by this paper
• Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity.

  2010cited by this paper
• Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

  2010cited by this paper
• Memantine depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase C in rat cerebral cortex nerve terminals: an NMDA receptor-independent mechanism.

  2010cited by this paper
• Metabolic and behavioral effects of chronic olanzapine treatment and cafeteria diet in rats

  2010cited by this paper
• Anti-aging herbal medicine--how and why can they be used in aging-associated neurodegenerative diseases?

  2010cited by this paper
• Alzheimer's disease: strategies for disease modification

  2010cited by this paper
• Update on the use of memantine in Alzheimer’s disease

  2009cited by this paper
• Use of Genetic Variation as Biomarkers for Alzheimer's Disease

  2009cited by this paper
• Social isolation prevents exercise‐induced proliferation of hippocampal progenitor cells in female rats

  2009cited by this paper
• Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.

  2009cited by this paper
• Pre-ischemic treatment with memantine reversed the neurochemical and behavioural parameters but not energy metabolites in middle cerebral artery occluded rats.

  2009cited by this paper
• Cdk5 Regulates the Phosphorylation of Tyrosine 1472 NR2B and the Surface Expression of NMDA Receptors

  2008cited by this paper
• Developing pharmacological therapies for Alzheimer disease

  2007cited by this paper
• NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies.

  2007cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• Inflammatory markers and the risk of Alzheimer disease

  2007cited by this paper
• PKA modulates GSK‐3β‐ and cdk5‐catalyzed phosphorylation of tau in site‐ and kinase‐specific manners

  2006cited by this paper
• Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine.

  2006cited by this paper
• Mechanism of action of memantine.

  2006cited by this paper
• Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

  2006cited by this paper
• Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.

  2005cited by this paper
• Olanzapine Attenuates the Okadaic Acid-Induced Spatial Memory Impairment and Hippocampal Cell Death in Rats

  2005cited by this paper
• Post-translational modifications of tau protein in Alzheimer’s disease

  2005cited by this paper
• Glutamate transporters: animal models to neurologic disease.

  2004cited by this paper
• Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

  2004cited by this paper
• Memantine in moderate-to-severe Alzheimer's disease.

  2003cited by this paper
• The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.

  2003cited by this paper
• Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats.

  2003cited by this paper
• Alzheimer' Disease as a Disconnection Syndrome?

  2003cited by this paper
• Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors

  2003cited by this paper
• Protein phosphatase 1 is a molecular constraint on learning and memory

  2002cited by this paper
• Okadaic acid induces epileptic seizures and hyperphosphorylation of the NR2B subunit of the NMDA receptor in rat hippocampus in vivo.

  2002cited by this paper
• A decade of CDK5

  2001cited by this paper
• Spatial memory deficit and neurodegeneration induced by the direct injection of okadaic acid into the hippocampus in rats

  2001cited by this paper
• Glutamate uptake.

  2001cited by this paper
• Role of protein phosphatase‐2A and ‐1 in the regulation of GSK‐3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain

  2000cited by this paper
• Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

  1999cited by this paper
• Memantine in severe dementia: results of the 9M‐best study (benefit and efficacy in severly demented patients during treatment with memantine)

  1999cited by this paper
• The glutamate receptor ion channels.

  1999cited by this paper
• The protein phosphatase inhibitor okadaic acid induces heat shock protein expression and neurodegeneration in rat hippocampus in vivo.

  1998cited by this paper
• Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease

  1998cited by this paper
• The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease.

  1998cited by this paper
• Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A.

  1995cited by this paper
• Cloned glutamate receptors.

  1994cited by this paper
• A brain-specific activator of cyclin-dependent kinase 5

  1994cited by this paper
• Protein serine/threonine phosphatases--new avenues for cell regulation.

  1994cited by this paper
• p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5

  1994cited by this paper
• Excitatory amino acids and synaptic transmission: the evidence for a physiological function.

  1990cited by this paper
• Alzheimer's disease.

  1986cited by this paper
• Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.

  1985cited by this paper
• A simplification of the protein assay method of Lowry et al. which is more generally applicable.

  1977cited by this paper

• Crocin Mitigates Glutamate Excitotoxicity and Tau Hyperphosphorylation by Modulating EAAT2 and Akt/Tau Pathway in a Scopolamine-induced Rat Model of Alzheimer's Disease.

  2026cites this paper
• Intracortical Injection of Okadaic Acid Increases Locomotor Activity and Decreases Anxiety-like Behaviour in Adult Male Rats: Potential Involvement of NMDA Receptor.

  2025cites this paper
• C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies.

  2023cites this paper
• Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment

  2022cites this paper
• The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease

  2021cites this paper
• Memantine treatment prevents okadaic acid induced neurotoxicity at the systemic and molecular levels

  2019cites this paper
• Memantine mediates astrocytic activity in response to excitotoxicity induced by PP2A inhibition.

  2019cites this paper
• Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride.

  2019cites this paper
• Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies

  2019cites this paper
• Toward Neuroproteomics in Biological Psychiatry: A Systems Approach Unravels Okadaic Acid-Induced Alterations in the Neuronal Phosphoproteome

  2017cites this paper
• Memantine for the Treatment of Dementia: A Review on its Current and Future Applications

  2017cites this paper
• Quercetin Protects against Okadaic Acid-Induced Injury via MAPK and PI3K/Akt/GSK3β Signaling Pathways in HT22 Hippocampal Neurons

  2016influential citation
• Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation

  2016cites this paper
• Intracerebroventricular administration of okadaic acid induces hippocampal glucose uptake dysfunction and tau phosphorylation.

  2016cites this paper
• Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification

  2016cites this paper
• Current approaches to enhance glutamate transporter function and expression

  2015cites this paper
• Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype

  2015cites this paper
• Rodent models of neuroinflammation for Alzheimer’s disease

  2015cites this paper
• Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype

  2015influential citation
• Rodent models of neuroinflammation for

  2015cites this paper
• Inhibition of Protein Phosphatase 2A: Focus on the Glutamatergic System

  2015cites this paper
• Molecular and Cellular Mechanism of Okadaic Acid (OKA)-Induced Neurotoxicity: A Novel Tool for Alzheimer’s Disease Therapeutic Application

  2014cites this paper
• Nandrolone-induced aggressive behavior is associated with alterations in extracellular glutamate homeostasis in mice.

  2014cites this paper
• In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals

  2014cites this paper
• Okadaic Acid: More than a Diarrheic Toxin

  2013cites this paper
• Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer's disease pathology.

  2013cites this paper
• Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer’s Disease

  2013cites this paper
• Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?

  2013cites this paper
• Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats

  2013cites this paper